← Back to Dashboard

Merimepodib

IMPDH inhibitor

2D Structure

Loading structure...

3D Structure

Loading 3D structure...

Chemical Identifiers

COC1=C(C=CC(=C1)NC(=O)NC2=CC=CC(=C2)CNC(=O)OC3CCOC3)C4=CN=CO4
JBPUGFODGPKTDW-SFHVURJKSA-N
ClinicalTrials.govPubMed

Clinical Development by Virus13

Hepacivirus C
HCV
Target: Human IMPDH
Phase 2
Preclinical
Phase 2
Phase 3
Approved
PMID:17629590
Chikungunya virus
CHIKV
Target: Human IMPDH
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:29126899
Human betaherpesvirus 5
CMV
Target: Human IMPDH
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:10722482
Zaire ebolavirus
EBOV
Target: Human IMPDH
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:29126899
Cardiovirus A
EMCV
Target: Human IMPDH
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:10722482
Hepatitis B virus
HBV
Target: Human IMPDH
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:10722482
Human respirovirus 3
HPIV-3
Target: Human IMPDH
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:10722482
Human alphaherpesvirus 1
HSV-1
Target: Human IMPDH
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:10722482
Argentinian mammarenavirus
JUNV
Target: Human IMPDH
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:29126899
Lassa mammarenavirus
LASV
Target: Human IMPDH
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:29126899
Human orthopneumovirus
RSV
Target: Human IMPDH
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:10722482
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:10722482
Zika virus
ZIKV
Target: Human IMPDH
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:29126899